How Can Latin America and the Caribbean Successfully Expand Emergency Vaccine Manufacturing?

lcornaro — Thu, 03 Mar 2022 11:55:45 +0000

The COVID-19 pandemic has pushed global vaccine manufacturing capacity to new limits and primed the pump for further expansion in regions like Latin America and the Caribbean (LAC) to prepare for future pandemic risks. The region has mainly relied on imports, with only 15 percent of total COVID-19 vaccine supply produced locally, which has made LAC vulnerable to nationalism, export bans, and shortages.

Blog Address:

Blog: https://www.cgdev.org/cgd-podcast

Author(s):

Morgan Pincombe

Javier Guzman

Why NICE’s Lack of Data Transparency Undermines Priority Setting in Low- and Middle- Income Countries

lcornaro — Wed, 16 Feb 2022 09:48:01 +0000

As low- and middle-income countries (LMICs) seek to deliver universal health coverage (UHC), they are finding it necessary to prioritize which services to provide, to whom, and at what cost. Health technology assessment (HTA) is increasingly being used to help identify which treatments provide the best value for money but as the capacity for conducting HTA is limited in LMICs, policy makers often rely upon evidence from established international HTA agencies to inform their decisions.

Blog Address:

Blog: https://www.cgdev.org/cgd-podcast

Author(s):

Srobana Ghosh

Justice Nonvignon

Leeza Osipenko

Andres Pichon Riviere

Javier Guzman

The COVID-19 Vaccine Rollout Was the Fastest in Global History, but Low-Income Countries Were Left Behind

lcornaro — Wed, 09 Feb 2022 10:47:09 +0000

The reaction to COVID-19 has been record-breaking. Today we release a paper that reports on the development and rollout of COVID-19 vaccines in historical perspective, and it suggests a pattern of unparalleled, but still deeply inequitable, progress.

Blog Address:

Blog: https://www.cgdev.org/cgd-podcast

Author(s):

Amanda Glassman

Charles Kenny

George Yang

One Health: Placing Human, Animal, and Environmental Issues at the Heart of COVID-19 Recovery in the Asia-Pacific Region

lcornaro — Wed, 09 Feb 2022 10:43:58 +0000

“One Health” is a trans-disciplinary approach to human, animal, and environmental health. The model addresses key health challenges, including zoonotic and vector-borne disease threats, antimicrobial resistance (AMR), food safety and security, and the human health impact of pollution and climate change. The essence of One Health is interdependence: no one dimension can be addressed singularly. In other words, One Health simultaneously promotes a healthy ecosystem, a healthy community, and healthy people living sustainably.

Blog Address:

Blog: https://www.cgdev.org/cgd-podcast

Author(s):

Najibullah Habib

Jane Parry

Javier Guzman

Azusa Sato

A Defining Moment for Medicines Regulation in Africa: The Establishment of the African Medicines Agency

hschoech — Thu, 03 Feb 2022 18:13:52 +0000

As of October 5, 2021, 15 African countries ratified the African Medicines Agency (AMA) treaty, entering into force the second specialized health agency of the African Union. The treaty struggled to get sufficient support for more than a decade after AMA was conceptualized at the 60^th World Health Organizational Regional Committee for Africa session and more than two years after its adoption in February 2019.

Blog Address:

Blog: https://www.cgdev.org/cgd-podcast

Author(s):

Morgan Pincombe

Javier Guzman

What if We Could Eliminate Lead Poisoning as a Threat to All Children?

hschoech — Wed, 02 Feb 2022 18:38:00 +0000

Remember when you first heard about the lead-water crisis in Flint, Michigan? Remember your outrage that America’s most vulnerable children were exposed to a dangerous, debilitating poison? Remember your disbelief that policymakers could allow this to happen, or other Americans could look away from the tremendous injustice?

Blog Address:

Blog: https://www.cgdev.org/cgd-podcast

Author(s):

Rachel Silverman

Africa CDC’s Health Economics Unit: More Important than Ever

hschoech — Mon, 31 Jan 2022 17:46:32 +0000

Never before has the health of the population been so front-of-mind for so many people. African countries continue to face multiple burdens with limited resources, and COVID-19 has brought a new awareness of how vulnerable health systems can be.

Blog Address:

Blog: https://www.cgdev.org/cgd-podcast

Author(s):

Justice Nonvignon

Elias Asfaw

Peter Baker

Tom Drake

Breaking the Omicron Wave: Three Actions to Protect Healthcare Workers in Low- and Middle- Income Countries

lcornaro — Mon, 31 Jan 2022 13:22:29 +0000

The Omicron variant has rapidly become the dominant variant of COVID-19, with many low- and middle- income countries (LMICs) observing a rapid increase in cases. In this blog we argue that protecting healthcare workers, and health systems in general, is now an even higher priority. We propose three strategies that policy makers could implement immediately to achieve this goal.

Blog Address:

Blog: https://www.cgdev.org/cgd-podcast

Author(s):

Lydia Regan

Tom Drake

Javier Guzman

Peter Baker

Could Decentralized Purchasing by Health Facilities Improve Access to Essential Medicines?

lcornaro — Fri, 28 Jan 2022 13:44:52 +0000

Low- and lower-middle-income countries (LMICs) and international development organizations have implemented a wide range of interventions to improve the functioning of government-run supply chains for health products over the last few decades. These efforts have helped to improve the availability of drugs for HIV/AIDS, malaria, tuberculosis, and sexual and reproductive health, and of other donor-funded medicines.

Blog Address:

Blog: https://www.cgdev.org/cgd-podcast

Author(s):

Lyudmila Nepomnyashchiy

Prashant Yadav

Drug-Resistant Infections Are One of the World’s Biggest Killers, Especially for Children in Poorer Countries. We Need to Act Now.

lcornaro — Thu, 20 Jan 2022 16:35:02 +0000

A study out today in The Lancet shows that people in low- and middle-income countries are 1.5 times more likely to die from antimicrobial resistance (AMR) than those in high-income countries. This disparity is far greater still when you look at deaths amongst young children, most of whom would otherwise have gone on to live healthy lives. Among children under five who die from AMR, 99.65 percent are in low- or middle-income countries.

Blog Address:

Blog: https://www.cgdev.org/cgd-podcast

Author(s):

Anthony McDonnell

Katherine Klemperer